VM.V

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd.

CA$0.13

-0.01 -7.14% today

Price History

Not enough data

Key Stats

Market Cap

29.42M

Avg Volume

145,591

EPS

-CA$0.02

52W High

CA$0.20

52W Low

CA$0.07

Div. Yield

0.0%

Valuation

P/B Ratio

32.50

P/S Ratio

493.91

EV/EBITDA

-8.80

EV/Revenue

614.35

Margins

Gross Margin 0.0%

Operating Margin (5312.7%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(574.2%)

Return on Assets

(66.9%)

Liquidity & Leverage

Current Ratio

0.23

Quick Ratio

0.18

Debt / Equity

0.10

Total Cash

443,424

Total Debt

40,000

About

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.

voyageurpharmaceuticals.ca